XBIOTECH INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
XBIOTECH INC. (XBIT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $664.69 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2020-03-16
- XBIOTECH INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2019 was $664.69M.
- XBIOTECH INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2018 was -$15.40M.
- XBIOTECH INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2017 was -$26.03M.
- XBIOTECH INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2016 was -$8.75M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month as first filed |
|---|---|---|
| 2019-12-31 | $664.69M 10-K · filed 2020-03-16 | |
| 2018-12-31 | -$15.40M 10-K · filed 2020-03-16 | -$5.10M 10-K · filed 2019-03-14 |
| 2017-12-31 | -$26.03M 10-K · filed 2020-03-16 | -$5.76M 10-K · filed 2018-03-16 |
| 2016-12-31 | -$8.75M 10-K/A · filed 2019-03-15 | |
| 2015-12-31 | -$6.54M 10-K · filed 2018-03-16 | |
| 2014-12-31 | -$3.49M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |